<p>艾朗科动物健康（NYSE:ELAN - 获取免费报告）在周四发布给投资者的研究报告中，摩根士丹利将其目标价格从 18.00 美元上调至 22.00 美元。该公司目前对该股票的评级为 “持平”。摩根士丹利的目标价格意味着该股票相较于前一交易日收盘价有 0.97% 的潜在下跌空间。</p>
<p>获取 <strong>艾朗科动物健康</strong> 的提醒：</p>
<ul>
<li>看涨还是看跌？评估动物健康护理股票</li>
</ul>
<p>其他研究分析师也对该公司发布了研究报告。摩根大通将艾朗科动物健康的评级从 “中性” 上调至 “增持”，并在 10 月 7 日的研究报告中将其目标价格从 18.00 美元上调至 24.00 美元。瑞银集团在 11 月 6 日的报告中将艾朗科动物健康的目标价格从 25.00 美元上调至 27.00 美元，并给予该公司 “买入” 评级。Stifel Nicolaus 在 9 月 24 日的研究报告中将艾朗科动物健康的目标价格从 18.00 美元上调至 23.00 美元，并给予该股票 “买入” 评级。巴克莱在 12 月 9 日的研究报告中开始覆盖艾朗科动物健康的股票，设定了 “增持” 评级和 30.00 美元的目标价格。最后，KeyCorp 在 12 月 10 日的研究报告中重新发布了对艾朗科动物健康的 “增持” 评级。两位分析师给予该股票 “强烈买入” 评级，七位给予 “买入” 评级，三位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “适度买入”，共识目标价格为 23.78 美元。</p>
<p><strong>获取我们对艾朗科动物健康的最新分析</strong></p>
<h2>艾朗科动物健康股价上涨 0.6%</h2>
<ul>
<li>Zoetis 宣布新股息，暗示被低估</li>
</ul>
<p>艾朗科动物健康的股票在周四上涨 0.14 美元，达到 22.22 美元。该公司交易了 1,352,910 股股票，而其平均交易量为 5,835,690 股。该公司的债务与股本比率为 0.59，速动比率为 1.23，流动比率为 2.40。该股票的市值为 110.4 亿美元，市盈率为 370.48，市盈增长比率为 3.44，贝塔值为 1.86。该公司的 50 日简单移动平均线为 21.82 美元，200 日简单移动平均线为 18.25 美元。艾朗科动物健康的股价在过去一年内最低为 8.02 美元，最高为 23.70 美元。</p>
<p>艾朗科动物健康（NYSE:ELAN - 获取免费报告）最近在 11 月 5 日发布了季度财报。该公司报告季度每股收益为 0.19 美元，超出市场共识预期的 0.13 美元，超出幅度为 0.06 美元。该公司季度收入为 11.4 亿美元，而市场共识预期为 10.9 亿美元。艾朗科动物健康的股本回报率为 7.41%，净利润率为 0.78%。该公司的季度收入同比增长 10.4%。在去年同期，该公司每股收益为 0.13 美元。艾朗科动物健康将其 2025 财年的每股收益指导区间设定为 0.910-0.940 美元，2025 年第四季度的指导区间为 0.090-0.120 美元。股票分析师预测艾朗科动物健康在当前年度将发布 0.91 美元的每股收益。</p>
<h2>艾朗科动物健康的内部买卖</h2>
<ul>
<li>2 只具有重大上行潜力的对冲基金股票</li>
</ul>
<p>在相关消息中，内部人士 Rajeev A. Modi 在 12 月 11 日的交易中购买了 4,500 股艾朗科动物健康的股票。该股票的平均购买价格为每股 21.33 美元，总价值为 95,985.00 美元。交易后，该内部人士直接持有该公司 123,082 股股票，价值约为 2,625,339.06 美元。这代表了他们持股比例的 3.79% 的增加。此次收购在 SEC 的法律文件中披露，相关信息可通过 SEC 网站访问。此外，首席执行官 Jeffrey N. Simmons 在 12 月 11 日的交易中购买了 22,000 股该公司的股票。该股票的平均购买成本为每股 21.75 美元，总交易额为 478,500.00 美元。收购完成后，首席执行官直接持有该公司 167,000 股股票，价值约为 3,632,250 美元。这代表了他们持股比例的 15.17% 的增加。此次购买的 SEC 文件提供了更多信息。在过去 90 天内，内部人士共购买了价值 937,883 美元的 43,450 股公司股票。公司内部人士持有该股票的比例为 0.89%。</p>
<h2>对艾朗科动物健康的对冲基金看法</h2>
<p>最近几位大型投资者对 ELAN 的持股进行了调整。SJS Investment Consulting Inc. 在第三季度将其在 Elanco Animal Health 的持股增加了 2,563.5%。SJS Investment Consulting Inc. 目前拥有该公司 1,385 股股票，价值 28,000 美元，此前在上个季度又购买了 1,333 股。Huntington National Bank 在第三季度将其在 Elanco Animal Health 的持股提高了 136.7%。Huntington National Bank 目前拥有该公司 1,882 股股票，价值 38,000 美元，此前在上个季度又购买了 1,087 股。Whittier Trust Co. of Nevada Inc. 在第三季度将其在 Elanco Animal Health 的持股增加了 80.3%。Whittier Trust Co. of Nevada Inc. 目前拥有该公司 2,021 股股票，价值 42,000 美元，此前在上个季度又购买了 900 股。Farther Finance Advisors LLC 在第三季度将其在 Elanco Animal Health 的持股增加了 79.3%。Farther Finance Advisors LLC 目前拥有该公司 2,151 股股票，价值 43,000 美元，此前在上个季度又购买了 951 股。最后，First Horizon Advisors Inc. 在第二季度将其在 Elanco Animal Health 的持股增加了 184.3%。First Horizon Advisors Inc. 目前拥有该公司 3,724 股股票，价值 53,000 美元，此前在上个季度又购买了 2,414 股。对冲基金和其他机构投资者持有该公司 97.48% 的股票。</p>
<h2>关于 Elanco Animal Health</h2>
<p>(获取免费报告)</p>
<p>Elanco Animal Health Incorporated 是一家动物健康公司，创新、开发、制造和销售宠物和农场动物的产品。它提供宠物健康疾病预防产品，如驱虫剂和疫苗产品，保护宠物免受蠕虫、跳蚤和蜱虫的侵害，品牌包括 Seresto、Advantage、Advantix 和 Advocate；针对犬猫的疼痛、骨关节炎、耳部感染、心血管和皮肤病的宠物健康治疗产品，品牌包括 Galliprant 和 Claro；用于家禽和水产养殖生产的疫苗、抗生素、驱虫剂及其他产品，以及营养健康产品，包括酶、益生菌和益生元；以及用于反刍动物和猪生产的一系列疫苗、抗生素、植入物、驱虫剂及其他产品，品牌包括 Rumensin 和 Baytril。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票，而不是 Elanco Animal Health</li>
<li>股票分红削减发生了，你准备好了吗？</li>
<li>Dollar General 的转机可能会在 2026 年推动股票上涨</li>
<li>经纪公司排名在股票选择中的重要性</li>
<li>不要对 AppLovin 下赌注：反对空头的理由</li>
<li>加拿大便士股票：它们能让你致富吗？</li>
<li>美光的第一季度业绩表明 “人工智能泡沫远未破裂”</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMQU4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMQU4"/></p>
<p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Elanco Animal Health 吗？</h2>
<p>在考虑 Elanco Animal Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Elanco Animal Health 并不在名单上。</p>
<p>虽然 Elanco Animal Health 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

ELAN

<p>摩根士丹利将 Elanco Animal Health 的目标股价从 18.00 美元上调至 22.00 美元，维持 “持平” 评级。其他分析师，包括摩根大通和瑞银，也提高了他们的目标股价，评级范围从 “买入” 到 “增持”。该股票的共识评级为 “适度买入”，共识目标股价为 23.78 美元。报告显示内部人士有买入活动，公司高管进行了大量股票收购</p>

<p>Elanco Animal Health (NYSE:ELAN - Get Free Report) had its price objective boosted by stock analysts at Morgan Stanley from $18.00 to $22.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has an &#34;equal weight&#34; rating on the stock. Morgan Stanley's target price points to a potential downside of 0.97% from the stock's previous close.</p>
<div class="lb-trans"><p>艾朗科动物健康（NYSE:ELAN - 获取免费报告）在周四发布给投资者的研究报告中，摩根士丹利将其目标价格从 18.00 美元上调至 22.00 美元。该公司目前对该股票的评级为 “持平”。摩根士丹利的目标价格意味着该股票相较于前一交易日收盘价有 0.97% 的潜在下跌空间。</p>
</div><p>Get <strong>Elanco Animal Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>艾朗科动物健康</strong> 的提醒：</p>
</div><ul>
<li>Bullish or Bearish? Vetting Animal Health Care Stocks</li>
</ul>
<div class="lb-trans"><ul>
<li>看涨还是看跌？评估动物健康护理股票</li>
</ul>
</div><p>Other research analysts have also issued research reports about the company. JPMorgan Chase &amp; Co. raised Elanco Animal Health from a &#34;neutral&#34; rating to an &#34;overweight&#34; rating and upped their price target for the company from $18.00 to $24.00 in a research report on Tuesday, October 7th. UBS Group lifted their price target on shares of Elanco Animal Health from $25.00 to $27.00 and gave the company a &#34;buy&#34; rating in a report on Thursday, November 6th. Stifel Nicolaus raised their target price on shares of Elanco Animal Health from $18.00 to $23.00 and gave the stock a &#34;buy&#34; rating in a research report on Wednesday, September 24th. Barclays began coverage on shares of Elanco Animal Health in a research report on Tuesday, December 9th. They set an &#34;overweight&#34; rating and a $30.00 price target on the stock. Finally, KeyCorp reissued an &#34;overweight&#34; rating on shares of Elanco Animal Health in a research note on Wednesday, December 10th. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $23.78.</p>
<div class="lb-trans"><p>其他研究分析师也对该公司发布了研究报告。摩根大通将艾朗科动物健康的评级从 “中性” 上调至 “增持”，并在 10 月 7 日的研究报告中将其目标价格从 18.00 美元上调至 24.00 美元。瑞银集团在 11 月 6 日的报告中将艾朗科动物健康的目标价格从 25.00 美元上调至 27.00 美元，并给予该公司 “买入” 评级。Stifel Nicolaus 在 9 月 24 日的研究报告中将艾朗科动物健康的目标价格从 18.00 美元上调至 23.00 美元，并给予该股票 “买入” 评级。巴克莱在 12 月 9 日的研究报告中开始覆盖艾朗科动物健康的股票，设定了 “增持” 评级和 30.00 美元的目标价格。最后，KeyCorp 在 12 月 10 日的研究报告中重新发布了对艾朗科动物健康的 “增持” 评级。两位分析师给予该股票 “强烈买入” 评级，七位给予 “买入” 评级，三位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “适度买入”，共识目标价格为 23.78 美元。</p>
</div><p><strong>Get Our Latest Analysis on Elanco Animal Health</strong></p>
<div class="lb-trans"><p><strong>获取我们对艾朗科动物健康的最新分析</strong></p>
</div><h2>Elanco Animal Health Trading Up 0.6%</h2>
<div class="lb-trans"><h2>艾朗科动物健康股价上涨 0.6%</h2>
</div><ul>
<li>Zoetis Declares New Dividend, Hinting At Undervaluation</li>
</ul>
<div class="lb-trans"><ul>
<li>Zoetis 宣布新股息，暗示被低估</li>
</ul>
</div><p>Shares of ELAN stock traded up $0.14 on Thursday, hitting $22.22. 1,352,910 shares of the company's stock traded hands, compared to its average volume of 5,835,690. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.23 and a current ratio of 2.40. The stock has a market capitalization of $11.04 billion, a price-to-earnings ratio of 370.48, a P/E/G ratio of 3.44 and a beta of 1.86. The company's fifty day simple moving average is $21.82 and its 200 day simple moving average is $18.25. Elanco Animal Health has a one year low of $8.02 and a one year high of $23.70.</p>
<div class="lb-trans"><p>艾朗科动物健康的股票在周四上涨 0.14 美元，达到 22.22 美元。该公司交易了 1,352,910 股股票，而其平均交易量为 5,835,690 股。该公司的债务与股本比率为 0.59，速动比率为 1.23，流动比率为 2.40。该股票的市值为 110.4 亿美元，市盈率为 370.48，市盈增长比率为 3.44，贝塔值为 1.86。该公司的 50 日简单移动平均线为 21.82 美元，200 日简单移动平均线为 18.25 美元。艾朗科动物健康的股价在过去一年内最低为 8.02 美元，最高为 23.70 美元。</p>
</div><p>Elanco Animal Health (NYSE:ELAN - Get Free Report) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.13 by $0.06. The firm had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.09 billion. Elanco Animal Health had a return on equity of 7.41% and a net margin of 0.78%.The company's quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.13 earnings per share. Elanco Animal Health has set its FY 2025 guidance at 0.910-0.940 EPS and its Q4 2025 guidance at 0.090-0.120 EPS. Equities analysts forecast that Elanco Animal Health will post 0.91 EPS for the current year.</p>
<div class="lb-trans"><p>艾朗科动物健康（NYSE:ELAN - 获取免费报告）最近在 11 月 5 日发布了季度财报。该公司报告季度每股收益为 0.19 美元，超出市场共识预期的 0.13 美元，超出幅度为 0.06 美元。该公司季度收入为 11.4 亿美元，而市场共识预期为 10.9 亿美元。艾朗科动物健康的股本回报率为 7.41%，净利润率为 0.78%。该公司的季度收入同比增长 10.4%。在去年同期，该公司每股收益为 0.13 美元。艾朗科动物健康将其 2025 财年的每股收益指导区间设定为 0.910-0.940 美元，2025 年第四季度的指导区间为 0.090-0.120 美元。股票分析师预测艾朗科动物健康在当前年度将发布 0.91 美元的每股收益。</p>
</div><h2>Insider Buying and Selling at Elanco Animal Health</h2>
<div class="lb-trans"><h2>艾朗科动物健康的内部买卖</h2>
</div><ul>
<li>2 Contrarian Stock Picks With Major Upside</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只具有重大上行潜力的对冲基金股票</li>
</ul>
</div><p>In related news, insider Rajeev A. Modi acquired 4,500 shares of Elanco Animal Health stock in a transaction that occurred on Thursday, December 11th. The stock was bought at an average price of $21.33 per share, with a total value of $95,985.00. Following the transaction, the insider directly owned 123,082 shares in the company, valued at approximately $2,625,339.06. This represents a 3.79% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Jeffrey N. Simmons bought 22,000 shares of the company's stock in a transaction on Thursday, December 11th. The stock was bought at an average cost of $21.75 per share, for a total transaction of $478,500.00. Following the completion of the acquisition, the chief executive officer directly owned 167,000 shares of the company's stock, valued at approximately $3,632,250. This represents a 15.17% increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 43,450 shares of company stock worth $937,883 in the last ninety days. 0.89% of the stock is owned by company insiders.</p>
<div class="lb-trans"><p>在相关消息中，内部人士 Rajeev A. Modi 在 12 月 11 日的交易中购买了 4,500 股艾朗科动物健康的股票。该股票的平均购买价格为每股 21.33 美元，总价值为 95,985.00 美元。交易后，该内部人士直接持有该公司 123,082 股股票，价值约为 2,625,339.06 美元。这代表了他们持股比例的 3.79% 的增加。此次收购在 SEC 的法律文件中披露，相关信息可通过 SEC 网站访问。此外，首席执行官 Jeffrey N. Simmons 在 12 月 11 日的交易中购买了 22,000 股该公司的股票。该股票的平均购买成本为每股 21.75 美元，总交易额为 478,500.00 美元。收购完成后，首席执行官直接持有该公司 167,000 股股票，价值约为 3,632,250 美元。这代表了他们持股比例的 15.17% 的增加。此次购买的 SEC 文件提供了更多信息。在过去 90 天内，内部人士共购买了价值 937,883 美元的 43,450 股公司股票。公司内部人士持有该股票的比例为 0.89%。</p>
</div><h2>Hedge Funds Weigh In On Elanco Animal Health</h2>
<div class="lb-trans"><h2>对艾朗科动物健康的对冲基金看法</h2>
</div><p>Several large investors have recently modified their holdings of ELAN. SJS Investment Consulting Inc. boosted its stake in Elanco Animal Health by 2,563.5% in the 3rd quarter. SJS Investment Consulting Inc. now owns 1,385 shares of the company's stock worth $28,000 after purchasing an additional 1,333 shares in the last quarter. Huntington National Bank raised its holdings in Elanco Animal Health by 136.7% in the third quarter. Huntington National Bank now owns 1,882 shares of the company's stock worth $38,000 after buying an additional 1,087 shares during the last quarter. Whittier Trust Co. of Nevada Inc. lifted its stake in shares of Elanco Animal Health by 80.3% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 2,021 shares of the company's stock worth $42,000 after buying an additional 900 shares in the last quarter. Farther Finance Advisors LLC grew its holdings in shares of Elanco Animal Health by 79.3% during the third quarter. Farther Finance Advisors LLC now owns 2,151 shares of the company's stock valued at $43,000 after buying an additional 951 shares during the last quarter. Finally, First Horizon Advisors Inc. increased its position in shares of Elanco Animal Health by 184.3% during the second quarter. First Horizon Advisors Inc. now owns 3,724 shares of the company's stock valued at $53,000 after acquiring an additional 2,414 shares in the last quarter. Hedge funds and other institutional investors own 97.48% of the company's stock.</p>
<div class="lb-trans"><p>最近几位大型投资者对 ELAN 的持股进行了调整。SJS Investment Consulting Inc. 在第三季度将其在 Elanco Animal Health 的持股增加了 2,563.5%。SJS Investment Consulting Inc. 目前拥有该公司 1,385 股股票，价值 28,000 美元，此前在上个季度又购买了 1,333 股。Huntington National Bank 在第三季度将其在 Elanco Animal Health 的持股提高了 136.7%。Huntington National Bank 目前拥有该公司 1,882 股股票，价值 38,000 美元，此前在上个季度又购买了 1,087 股。Whittier Trust Co. of Nevada Inc. 在第三季度将其在 Elanco Animal Health 的持股增加了 80.3%。Whittier Trust Co. of Nevada Inc. 目前拥有该公司 2,021 股股票，价值 42,000 美元，此前在上个季度又购买了 900 股。Farther Finance Advisors LLC 在第三季度将其在 Elanco Animal Health 的持股增加了 79.3%。Farther Finance Advisors LLC 目前拥有该公司 2,151 股股票，价值 43,000 美元，此前在上个季度又购买了 951 股。最后，First Horizon Advisors Inc. 在第二季度将其在 Elanco Animal Health 的持股增加了 184.3%。First Horizon Advisors Inc. 目前拥有该公司 3,724 股股票，价值 53,000 美元，此前在上个季度又购买了 2,414 股。对冲基金和其他机构投资者持有该公司 97.48% 的股票。</p>
</div><h2>About Elanco Animal Health</h2>
<div class="lb-trans"><h2>关于 Elanco Animal Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands.</p>
<div class="lb-trans"><p>Elanco Animal Health Incorporated 是一家动物健康公司，创新、开发、制造和销售宠物和农场动物的产品。它提供宠物健康疾病预防产品，如驱虫剂和疫苗产品，保护宠物免受蠕虫、跳蚤和蜱虫的侵害，品牌包括 Seresto、Advantage、Advantix 和 Advocate；针对犬猫的疼痛、骨关节炎、耳部感染、心血管和皮肤病的宠物健康治疗产品，品牌包括 Galliprant 和 Claro；用于家禽和水产养殖生产的疫苗、抗生素、驱虫剂及其他产品，以及营养健康产品，包括酶、益生菌和益生元；以及用于反刍动物和猪生产的一系列疫苗、抗生素、植入物、驱虫剂及其他产品，品牌包括 Rumensin 和 Baytril。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Elanco Animal Health</li>
<li>Stock Dividend Cuts Happen Are You Ready?</li>
<li>Dollar General's Turnaround Could Send the Stock Higher in 2026</li>
<li>The Significance of Brokerage Rankings in Stock Selection</li>
<li>Don’t Bet Against AppLovin: The Case Against the Shorts</li>
<li>Canadian Penny Stocks: Can They Make You Rich?</li>
<li>Micron’s Q1 Results Say “AI Bubble Is Far From Bursting”</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 Elanco Animal Health</li>
<li>股票分红削减发生了，你准备好了吗？</li>
<li>Dollar General 的转机可能会在 2026 年推动股票上涨</li>
<li>经纪公司排名在股票选择中的重要性</li>
<li>不要对 AppLovin 下赌注：反对空头的理由</li>
<li>加拿大便士股票：它们能让你致富吗？</li>
<li>美光的第一季度业绩表明 “人工智能泡沫远未破裂”</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMQU4" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=ELAN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Elanco Animal Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Elanco Animal Health 吗？</h2>
</div><p>Before you consider Elanco Animal Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Elanco Animal Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elanco Animal Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Elanco Animal Health 并不在名单上。</p>
</div><p>While Elanco Animal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Elanco Animal Health 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Elanco Animal Health（NYSE 代码：ELAN）的目标股价被上调至 22.00 美元